InsiderClue
Stocks · Health care · Pharmaceutical Preparations

Oruka Therapeutics, Inc.

ORKA Clue Score22
United States Fiscal year ends December CIK 0000907654 Results filed 10 Aug 2026
Add to watchlist

What the insiders did Mostly scheduled

Individual transactions

34
Insider
Date
Role
Action
Shares
Price
Amount
Laura Lee Sandler
15 Sep 2026
Chief Operating Officer
Sell
906
$95.71
$86.71K
Paul T Quinlan
15 Sep 2026
General Counsel
Sell
1,039
$95.71
$99.44K
Lawrence Otto Klein
15 Sep 2026
Chief Executive Officer
Sell
2,452
$95.71
$234.68K
Paul T Quinlan
15 Jun 2026
General Counsel
Sell
733
$69.69
$51.08K
Laura Lee Sandler
15 Jun 2026
Chief Operating Officer
Sell
600
$69.69
$41.81K
Lawrence Otto Klein
15 Jun 2026
Chief Executive Officer
Sell
1,729
$69.69
$120.49K
Paul T Quinlan
16 Mar 2026
General Counsel
Sell
733
$41.30
$30.27K
Laura Lee Sandler
16 Mar 2026
Chief Operating Officer
Sell
600
$41.30
$24.78K
Arjun Agarwal
16 Mar 2026
Senior Vice President, Finance
Sell
395
$41.30
$16.31K
Lawrence Otto Klein
16 Mar 2026
Chief Executive Officer
Sell
1,729
$41.30
$71.41K
Thomas A Keuer
3 Apr 2018
Chief Operating Officer
Sell
482
$0.50
$241.72
Brian L. Selby
2 Apr 2018
VP, Finance
Sell
1,114
$0.50
$556.33
Thomas A Keuer
28 Feb 2018
Chief Operating Officer
Sell
410
$0.72
$294.38
Venrock Healthcare Capital Partners LP
27 Feb 2018
10% owner
Sell indirect
41,331
$0.53
$21.91K
Brian L. Selby
27 Feb 2018
VP, Finance
Sell
161
$0.53
$85.33
Growth Equity Opportunities IV, LLC
26 Feb 2018
10% owner
Sell
1,460,209
$0.50
$731.27K
Peter J Barris
26 Feb 2018
10% owner
Sell indirect
1,460,209
$0.50
$731.27K
Forest Baskett
26 Feb 2018
10% owner
Sell indirect
1,460,209
$0.50
$731.27K
Anthony A. Florence Jr.
26 Feb 2018
10% owner
Sell indirect
1,460,209
$0.50
$731.27K
Joshua Makower
26 Feb 2018
10% owner
Sell indirect
1,460,209
$0.50
$731.27K
David M Mott
26 Feb 2018
10% owner
Sell indirect
1,460,209
$0.50
$731.27K
Jon Sakoda
26 Feb 2018
10% owner
Sell indirect
1,460,209
$0.50
$731.27K
Scott D Sandell
26 Feb 2018
10% owner
Sell indirect
1,460,209
$0.50
$731.27K
Peter W. Sonsini
26 Feb 2018
10% owner
Sell indirect
1,460,209
$0.50
$731.27K
Ravi Viswanathan
26 Feb 2018
10% owner
Sell indirect
1,460,209
$0.50
$731.27K
Venrock Healthcare Capital Partners LP
26 Feb 2018
10% owner
Sell indirect
1,500,000
$0.55
$825.00K
Michael R Bristow
4 Apr 2017
Pres. & Chief Executive Offic
Sell
720
$2.41
$1.74K
Thomas A Keuer
4 Apr 2017
Chief Operating Officer
Sell
390
$2.41
$939.90
Christopher David Ozeroff
4 Apr 2017
S.V.P., General Counsel
Sell
418
$2.41
$1.01K
Brian L. Selby
3 Apr 2017
VP, Finance
Sell
1,114
$2.46
$2.74K
Michael R Bristow
28 Feb 2017
Pres. & Chief Executive Offic
Sell
763
$2.61
$1.99K
Thomas A Keuer
28 Feb 2017
Chief Operating Officer
Sell
465
$2.61
$1.21K
Christopher David Ozeroff
28 Feb 2017
S.V.P., General Counsel
Sell
465
$2.61
$1.21K
Brian L. Selby
27 Feb 2017
VP, Finance
Sell
161
$2.56
$412.16
Show all 208 transactions →

What was left out

Form 4 filings counted 164
Amendments (4/A) skipped 1
Filings about a different issuer 0
Unreadable filings 0
Joint filings 24
Sales on a Rule 10b5-1 plan 7
Sales straight out of an exercise 110
Sales at will 34
Transactions with no price 0
Shares from compensation/vesting 11,807,846
Sales filed before the plan box existed 24
History held since 2 Oct 2006